[Experience with the use of gefitinib in patients with inoperable non-squamous cell lung cancer with activating EGFR mutations]. [electronic resource]
Producer: 20150727Description: 259-65 p. digitalISSN:- 0507-3758
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease-Free Survival
- ErbB Receptors -- genetics
- Female
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Prospective Studies
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.